The upregulation of epithelial markers and the downregulation of mesenchymal markers suggested that HOXB9 could induce MET, which was the reverse of EMT in GC cells, and therefore suppress tumorigenic process within these cells. The gene discussed is HOXB9; the disease is gastric cancer.